Results 131 to 140 of about 19,263 (243)

P05: DARATUMUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE VERSUS LENALIDOMIDE AND DEXAMETHASONE ALONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: OVERALL SURVIVAL RESULTS FROM THE PHASE 3 POLLUX TRIAL

, 2022
Meletios Α. Dimopoulos, A Oriol, Hareth Nahi, Jesús F. San Miguel, NJ Bahlis, S. Z. Usmani, N Rabin, RZ Orlowski, K Suzuki, T Plesner, SS Yoon, D Ben Yehuda, PG Richardson, H Goldschmidt, D Reece, T Ahmadi, X Qin, W Garvin Mayo, X Gai, Jodi Carey, R Carson, P. Moreau   +21 more
openalex   +1 more source

Autologous Stem Cell Collection after Daratumumab, Bortezomib, Thalidomide, and Dexamethasone versus Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma [PDF]

, 2023
Sandra Sauer, Katharina Kriegsmann, Cathleen Nientiedt, Anita Schmitt, Carsten Müller‐Tidow, Marc‐Steffen Raab, Joseph Kauer   +6 more
openalex   +1 more source

Management of daratumumab interference in Portuguese blood transfusion medicine: A literature review about unmet needs and challenges [PDF]

, 2018
Dialina Brilhante, Teresa Chabert, Anabela Brites, Fátima Nascimento, Maria José Rodrigues, José Antonio Durán, Sérgio Barroso, Rita Jaime, Ana Maria Esesumaga   +8 more
openalex   +1 more source

Supplementary Materials and Methods from Fratricide of NK Cells in Daratumumab Therapy for Multiple Myeloma Overcome by <i>Ex Vivo</i>–Expanded Autologous NK Cells

, 2023
Yufeng Wang, Yibo Zhang, Tiffany Hughes, Jianying Zhang, Michael A. Caligiuri, Don M. Benson, Jianhua Yu   +6 more
openalex   +1 more source

Successful Treatment of Plasmablastic Lymphoma with Daratumumab Plus CHOP: A Case Report [PDF]

Youhai Yuan, Zhixiang Wang, Wejun Huang, Shanshan Zhang, Qi Wei, Xutao Guo, Ru Feng, Yongqiang Wei, Yongqiang Wei   +8 more
openalex   +1 more source

Supplementary Data from BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression

, 2023
Lijie Xing, Su Wang, Jiye Liu, Tengteng Yu, Hailin Chen, Kenneth Wen, Yuyin Li, Liang Lin, Phillip A. Hsieh, Shih‐Feng Cho, Gang An, Lugui Qiu, Krista Kinneer, Nikhil C. Munshi, Kenneth C. Anderson, Yu‐Tzu Tai   +15 more
openalex   +1 more source

Efficacy and safety of intravenous daratumumab-based treatments for AL amyloidosis: a systematic review and meta-analysis [PDF]

, 2022
Chunyan Sun, Xiaohong Wang, Renyi Zhang, Lingjie Xu, Bin Wang, Li J   +5 more
openalex   +1 more source

Advancing multiple myeloma therapy: A systematic analysis of corticosteroids and monoclonal antibodies as dual therapeutic agents. [PDF]

World J Methodol
Alam F, Siddiqui H, Nihal A, Andleeb M, Zaman AQU, Khushk MI, Hussain F, Rai R, Fatima FB, Kumar D, Rizvi SAFA, Jabeen S, Jawed I, Qadir U, Zakeri MA.   +14 more
europepmc   +1 more source

Oral selinexor–dexamethasone for triple-class refractory multiple myeloma [PDF]

, 2019
al., et, Vij, Ravi
core   +1 more source

AQUILA: Dousing the Embers of Smoldering Multiple Myeloma With Daratumumab Monotherapy

Jodi Lipof, Darren Pan, Anupama D. Kumar, Alfred Chung, Ajai Chari   +4 more
openalex   +1 more source